Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - sodium chloride, quantity: 270 mg - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - indications as per 11 june 2002: indicated during surgical procedures where isotonic irrigation is required e.g. irrigation of body cavities, tissues or wounds, indwelling urethral catheters and surgical drainage tubes. dilution of medications prior to use in accordance with the product information for the medication being diluted e.g. to dilute inhalation solutions prior to nebulisation.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoo pets pty ltd - glucose; potassium as(k)citrate,(k)hydroxide,(k)phosphate monobas; citrate as potassium citrate; magnesium as magnesium sulfate; sulfate as magnesium sulfate; chloride as sodium chloride; sodium as sodium chloride; phosphate as potassium phosphate - oral solution/suspension - glucose carbohydrate active 260.0 g/l; potassium as(k)citrate,(k)hydroxide,(k)phosphate monobas mineral-potassium-base active 30.0 g/l; citrate as potassium citrate mineral-potassium active 35.0 g/l; magnesium as magnesium sulfate mineral-magnesium active 3.0 g/l; sulfate as magnesium sulfate mineral-magnesium active 12.0 g/l; chloride as sodium chloride mineral-sodium active 43.0 g/l; sodium as sodium chloride mineral-sodium-salt active 28.0 g/l; phosphate as potassium phosphate mineral-phosphorus active 17.0 g/l - nutrition & metabolism - dog - greyhound | racing greyhound - dehydration | electrolyte replacement

Israel - English - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; potassium chloride; sodium chloride; sodium lactate - solution for infusion - sodium lactate 0.32 %w/v; calcium chloride dihydrate 0.027 %w/v; potassium chloride 0.04 %w/v; sodium chloride 0.6 %w/v - calcium chloride - calcium chloride - source of water and electrolytes. regulation or maintenance of metabolic acidosis ( except lactic acidosis).

Malta - English - Medicines Authority

b braun melsungen ag carl-braun-strasse 1, d34212 melsungen, germany - calcium chloride, dihydrate, potassium chloride, sodium chloride, sodium lactate - solution for infusion - sodium chloride 6 g/l sodium lactate 3.12 g/l calcium chloride dihydrate 0.27 g/l potassium chloride 0.4 g/l - blood substitutes and perfusion solutions

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra ltd - sodium lactate ; sodium chloride ; potassium chloride; calcium chloride - solution for infusion - 3.2, 6, 0.4, 0.2 milligram(s)/millilitre - electrolytes - cats, cattle, dogs, horses - electrolytes

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - calcium chloride dihydrate, quantity: 67.5 mg; sodium chloride, quantity: 1.5 g; sodium lactate, quantity: 792.5 mg; potassium chloride, quantity: 100 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - compound sodium lactate (hartmann's solution) is used:,? for intravenous fluid and electrolyte replacement,? as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency,? as a vehicle for intravenous drug delivery, if the drugs are compatible with the solutions.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid; sodium chloride - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.